Bridgeworth’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bridgeworth’s Portfolio IBDM Stock Details IBDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,568	Closed	-$360K	–	156
2021 Q3	$360K	Hold	14,568	–	–	0.1%	98
2021 Q2	$361K	Hold	14,568	–	–	0.1%	95
2021 Q1	$362K	Hold	14,568	–	–	0.11%	86
2020 Q4	$363K	Hold	14,568	–	–	0.12%	82
2020 Q3	$365K	Hold	14,568	–	–	0.14%	80
2020 Q2	$366K	Hold	14,568	–	–	0.14%	85
2020 Q1	$359K	Hold	14,568	–	–	0.16%	80
2019 Q4	$364K	Hold	14,568	–	–	0.14%	86
2019 Q3	$364K	Hold	14,568	–	–	0.14%	84
2019 Q2	$363K	Buy	14,568 +1,861	+15%	+$46.1K	0.14%	79
2019 Q1	$314K	Buy	+12,707	New	+$312K	0.12%	90
2018 Q4	–	Hold	0	–	–	–	89
2018 Q3	–	Sell	-9,618	Closed	-$234K	–	110
2018 Q2	$234K	Buy	+9,618	New	+$234K	0.1%	120

Other funds holding IBDM

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bridgeworth's IBDM Position: Q4 2021 in Review

Bridgeworth sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q4 2021, closing a stake of 14,568 shares — an estimated $360K sold.

Bridgeworth first reported a position in IBDM in Q2 2018 and held it in 12 quarters. The position peaked at $366K in Q2 2020. 1 fund tracked by Wall St. Rank holds IBDM as of Q4 2021.

Bridgeworth reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q4 2021 after selling out during the quarter.
Bridgeworth sold 14,568 iShares iBonds Dec 2021 Term Corporate ETF shares in Q4 2021, an estimated $360K.
Bridgeworth first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q2 2018 and held it in 12 quarters.
Bridgeworth's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $366K in Q2 2020.
1 fund tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q4 2021.

Based on Bridgeworth's 13F filing for Q4 2021, filed 10 Feb 2022.